Form 8-K - Current report:
SEC Accession No. 0000950170-25-035963
Filing Date
2025-03-10
Accepted
2025-03-10 09:09:40
Documents
16
Period of Report
2025-03-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sclx-20250310.htm   iXBRL 8-K 48007
2 EX-99.1 sclx-ex99_1.htm EX-99.1 28179
3 GRAPHIC img191798281_0.jpg GRAPHIC 43426
4 GRAPHIC img191798281_1.jpg GRAPHIC 15252
5 GRAPHIC img191798281_2.jpg GRAPHIC 19678
6 GRAPHIC img191798281_3.jpg GRAPHIC 35969
  Complete submission text file 0000950170-25-035963.txt   407039

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sclx-20250310.xsd EX-101.SCH 60677
18 EXTRACTED XBRL INSTANCE DOCUMENT sclx-20250310_htm.xml XML 6490
Mailing Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303
Business Address 960 SAN ANTONIO ROAD PALO ALTO CA 94303 (650) 516-4310
Scilex Holding Co (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 25722365
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)